Search
Cullinan Therapeutics Inc
CGEMAdd to Watchlist
21.080USD
-0.280-1.31%
Close 09-18 16:00（ET）
1.36BMarket Cap
LossP/E TTM
After-hours 16:13 (ET)20.540USD-0.510-2.42%
After-hours 16:13 (ET)TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-1.31%
5 Days
+2.38%
1 Month
+1.15%
6 Months
+60.55%
Year to Date
+103.67%
1 Year
+232.49%
Key Figures
21.380Open
21.450High
199.80KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.31%Turnover Ratio
21.360Prev. Close
20.630Low
4.17MTurnover
LossP/E Static
4.22P/B
0.00%Div Yield TTM
-44.99%ROA
23.19052wk High
75.62Volume Ratio
-167.38MNet Profit
64.35MShares
-3.7216EPS TTM
-0.04Beta
-48.16%ROE
5.68052wk Low
3.51%Amplitude
--Gross Margin
1.36BMarket Cap
3.44Reward/Risk
4.94%Risk Rate
Cullinan Therapeutics Inc's Score
0.12vs previous score
Forecast9.08
Financial Health5.87
Technical5.31
Valuation Dimensions7.77
Institutional Confidence10.00
Risk Assessment5.56
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Cullinan Therapeutics Inc Technical Analysis
Technical Indicators
Buy
Summary
Buy
Moving Average
Strong buy
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.87/-0.81
Revenue / Forecast
--/0.00
Cullinan Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolCGEM
Number of employees111
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Lynx1 Capital Advisors LLC | 14.58% |
| MPM BioImpact LLC | 12.44% |
| BVF Partners L.P. | 9.36% |
| BlackRock Institutional Trust Company, N.A. | 6.32% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 45.32% |
| Investment Advisor/Hedge Fund | 29.37% |
| Hedge Fund | 24.94% |
| Research Firm | 2.81% |
Related Instruments
+0.04%
-0.09%
-0.04%
-0.02%
-0.19%
-0.39%
+1.55%
-0.52%
+0.07%
+0.12%
+0.35%
-1.55%
-1.65%
-1.53%
-0.56%
-0.58%
-0.55%
-2.55%
-0.73%
-0.42%Popular Instruments
51734.000
-26.000 (-0.05%)
29664.700
+252.000 (+0.86%)
7659.100
+27.000 (+0.35%)
14420.000
+119.000 (+0.83%)
65079.000
+130.000 (+0.20%)
6230.800
-76.400 (-1.21%)
96.001
-1.985 (-2.03%)
336.130
-0.870 (-0.26%)
222.270
+2.930 (+1.34%)
4377.330
+36.350 (+0.84%)
FAQs
What is the current price of Cullinan Therapeutics Inc (CGEM)?
The current price of Cullinan Therapeutics Inc (CGEM) is 21.08.
What is the symbol of Cullinan Therapeutics Inc?
The ticker symbol of Cullinan Therapeutics Inc is CGEM.
What is the 52-week high of Cullinan Therapeutics Inc?
The 52-week high of Cullinan Therapeutics Inc is 23.19.
What is the 52-week low of Cullinan Therapeutics Inc?
The 52-week low of Cullinan Therapeutics Inc is 5.68.
What is the market capitalization of Cullinan Therapeutics Inc?
The market capitalization of Cullinan Therapeutics Inc is 1.36B.
Is Cullinan Therapeutics Inc (CGEM) currently rated as Buy, Hold, or Sell?
According to analysts, Cullinan Therapeutics Inc (CGEM) has an overall rating of STRONG BUY, with a price target of 36.67.
What is the Earnings Per Share (EPS TTM) of Cullinan Therapeutics Inc (CGEM)?
The Earnings Per Share (EPS TTM) of Cullinan Therapeutics Inc (CGEM) is -3.72.